4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-20-023626
Chief Medical Officer acquired 5,515 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Detke Michael J. Chief Medical Officer | 2020-04-02 | Option exercise | +5,515 | $6.91 | $38,109 | 22,746 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Detke Michael J. Chief Medical Officer | 2020-04-02 | Option exercise · Stock Option (Right to Buy) | −5,515 | 109,606 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…